Overview

This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis

Status:
NOT_YET_RECRUITING

Trial end date:
2028-12-10

Target enrollment:

Participant gender:

Summary

This is an early exploratory study to assess the tolerability and safety of GC012F CAR T cell injection in Multiple Sclerosis patients.

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

Daishi Tian